Entrada Therapeutics, Inc. (TRDA) Earnings
|
Expand Research on TRDA
| Next EPS Date | 8/12/26 | EPS Growth Rate | -1.9% |
|---|---|---|---|
| Average EPS % Beat Rate | -5.7% | Revenue Growth Rate | +11.5% |
| Average % Move 1-Wk after EPS | -11.4% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/12/26  |
Q226 | N/A | -$1.06 | N/A | N/A | $2.23M | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.95 | -$1.02 | +$0.07 | $875K | $3.34M | N/A |  | | Details | |
| 2/26/26 |
Q425 | -$0.94 | -$0.98 | +$0.04 | $1.3M | $5.81M | N/A | | | Details | |
| 11/6/25 |
Q325 | -$1.06 | -$0.99 | -$0.07 | $1.6M | $7.03M | N/A | | | Details | |
| 8/6/25 | Q225 | -$1.04 | -$0.82 | -$0.22 | $2M | $9.65M | N/A | | | Details | |
| 5/8/25 | Q125 | -$0.42 | -$0.73 | +$0.31 | N/A | $11.64M | N/A | | | Details | |
| 3/3/25 |
Q424 | $0.03 | -$0.67 | +$0.70 | $37.4M | $13.34M | N/A | | | Details | |
| 11/5/24 | Q324 | -$0.35 | -$0.73 | +$0.38 | $19.57M | $12.32M | N/A | | | Details |
